Clinical study will use advanced MRI on breast cancer patients

A two-year clinical study is underway in which advanced imaging methods will be tested, with the hopes of providing valuable information, support and treatment to breast cancer patients and their physicians. The team will use MRI and analysis to make early predictions on how a specific patient’s tumor will eventually respond to therapy.

The clinical study is the first of its kind to focus primarily on cancer, and will be done through partnerships with Seton Healthcare Family, Texas Oncology and Austin Radiological Association and the University of Texas at Austin. The study is funded by the National Institutes of Health’s National Cancer Institute and the Cancer Prevention and Research Institute of Texas.

The study began Oct. 1 and the team plans to enroll 100 breast cancer patients from Seton and Texas Oncology. 

Read the full article below:

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.